Itau Unibanco Holding S.A. Boosts Stake in Agilent Technologies Inc (A)
Itau Unibanco Holding S.A. boosted its position in shares of Agilent Technologies Inc (NYSE:A) by 80.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,859 shares of the medical research company’s stock after purchasing an additional 3,500 shares during the quarter. Itau Unibanco Holding S.A.’s holdings in Agilent Technologies were worth $526,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. boosted its position in shares of Agilent Technologies by 8.1% in the 4th quarter. BlackRock Inc. now owns 25,665,358 shares of the medical research company’s stock worth $1,718,808,000 after purchasing an additional 1,912,186 shares in the last quarter. TimesSquare Capital Management LLC purchased a new position in shares of Agilent Technologies in the 3rd quarter valued at about $58,550,000. Bank of Montreal Can increased its stake in shares of Agilent Technologies by 187.3% in the 4th quarter. Bank of Montreal Can now owns 742,001 shares of the medical research company’s stock valued at $49,693,000 after purchasing an additional 483,721 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in Agilent Technologies by 27.6% in the 3rd quarter. Wells Fargo & Company MN now owns 2,184,502 shares of the medical research company’s stock worth $140,244,000 after buying an additional 473,047 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in Agilent Technologies by 47.1% in the 3rd quarter. Principal Financial Group Inc. now owns 1,315,644 shares of the medical research company’s stock worth $84,465,000 after buying an additional 421,438 shares during the last quarter.
Several brokerages have recently weighed in on A. Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 16th. Deutsche Bank set a $75.00 price objective on Agilent Technologies and gave the company a “buy” rating in a report on Tuesday, November 21st. JPMorgan Chase & Co. upped their price objective on Agilent Technologies to $75.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Barclays boosted their target price on Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Finally, Cowen reissued a “hold” rating and issued a $70.00 target price on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $71.27.
Agilent Technologies Inc (A) traded up $0.26 during midday trading on Thursday, reaching $70.18. 2,511,536 shares of the company traded hands, compared to its average volume of 2,920,000. The stock has a market capitalization of $22,630.00, a PE ratio of 31.33, a P/E/G ratio of 2.36 and a beta of 1.30. Agilent Technologies Inc has a 52-week low of $52.26 and a 52-week high of $75.00. The company has a quick ratio of 2.78, a current ratio of 3.23 and a debt-to-equity ratio of 0.40.
Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.58 by $0.08. Agilent Technologies had a net margin of 4.25% and a return on equity of 17.70%. The company had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.16 billion. During the same period last year, the company posted $0.53 earnings per share. equities research analysts predict that Agilent Technologies Inc will post 2.68 earnings per share for the current year.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.